Newsfeed The Lead

In new record high, India reports 3.86 lakh new Covid-19 cases, 3,498 deaths

Health officials taking random sampling in Jammu

New Delhi:  India reported 3.86 lakh new Covid-19 cases in the last 24 hours ending 8 am Friday, its sharpest spike since the pandemic first gripped the country last year. With this the total caseload rose to over 1.87 crore. Out of the total cases, over 31 lakh cases are currently active while over 1.53 crore people have recovered after testing positive. Meanwhile, with 3,498 deaths, the death toll surged to 2.08 lakh.

 

The national capital on Thursday recorded 395 deaths due to coronavirus, the highest since the pandemic began a year ago, and 24,235 cases with a positivity rate of 32.82 per cent, according to a bulletin issued by the city health department. This was the eighth day in a row that Delhi has recorded over 300 deaths due to COVID-19. The cumulative case count in the city stands at 11,22,286, of which over 10.08 lakh have recovered. The death toll due to the viral disease stands at 15,772.

 

The Centre on Thursday directed the states and Union territories to go for intensive local containment measures in the districts that have high number of COVID-19 cases to curb the spread of the viral disease. In the fresh guidelines issued May, the Ministry of Home Affairs (MHA), however, did not mention about the imposition of a lockdown anywhere.

 

Maharashtra government on Thursday extended the restrictions put in place to arrest the spread of Covid-19 till May 15. In an order released by the state, it said: “The Disaster Management Act, 2005, finds it is necessary to continue the enforcement of the current restrictions throughout the state beyond 7 AM on 1st May, 2021 till 7 AM on 15th May, 2021 to break the chain of transmission effectively.”

 

In a major development, Bharat Biotech today announced that Covaxin will be available to state governments at a price of Rs 400 per dose. The firm, which had earlier pegged the price of the vaccine at Rs 600 per dose for state governments, said in a statement: “Recognising the enormous challenges to the public health care system, we have made Covaxin available to state governments at a price of Rs 400/dose.”

 

 

Support Ethical Journalism. Support The Dispatch

The Dispatch is a sincere effort in ethical journalism. Truth, Accuracy, Independence, Fairness, Impartiality, Humanity and Accountability are key elements of our editorial policy. But we are still not able to generate great stories, because we don’t have adequate resources. As more and more media falls into corporate and political control, informed citizens across the world are funding independent journalism initiatives. Here is your chance to support your local media startup and help independent journalism survive. Click the link below to make a payment of your choice and be a stakeholder in public spirited journalism


 

The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies